Idera Pharma (IDRA) Updates on IMO-2125 Phase 1/2 in Metastatic Melanoma; Promising Data Noted
Go back to Idera Pharma (IDRA) Updates on IMO-2125 Phase 1/2 in Metastatic Melanoma; Promising Data Noted| Idera Pharmaceuticals, Inc. (NASDAQ: IDRA) | Delayed: 0.43 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.43 | 52 Week High | $4.42 | |||
| Open | $0.43 | 52 Week Low | $1.19 | |||
| Day High | $0.43 | P/E | N/A | |||
| Day Low | $0.43 | EPS | $-0.64 | |||
| Volume | 47,857 | |||||
